Market Tracker

05/27 4:09am ET

Endocyte Inc (NASDAQ:ECYT)

3.77
Delayed Data
As of May 26
 -0.10 / -2.58%
Today’s Change
2.65
Today|||52-Week Range
6.34
-5.99%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close3.87
Today’s open3.87
Day’s range3.77 - 3.98
Volume57,176
Average volume (3 months)193,790
Market cap$163.1M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-12.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.95

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc+0.13+1.46%
TBRATobira Therapeutics ...-0.03-0.34%
GLYCGlycoMimetics Inc-0.01-0.12%
TTPHTetraphase Pharmaceu...-0.08-1.84%
Data as of 05/26/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts